Tower Research Capital (TRC)’s Concord Medical Services CCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-10
| Closed | – | – | 5842 |
|
|
2022
Q4 | $0 | Buy |
+10
| New | +$156 | ﹤0.01% | 5925 |
|
|
2021
Q2 | – | Sell |
-23
| Closed | -$1K | – | 5495 |
|
|
2021
Q1 | $1K | Buy |
+23
| New | +$845 | ﹤0.01% | 5149 |
|
|
2017
Q4 | – | Sell |
-798
| Closed | -$28K | – | 3549 |
|
|
2017
Q3 | $28K | Sell |
798
-103
| -11% | -$4.08K | ﹤0.01% | 2488 |
|
|
2017
Q2 | $34K | Buy |
901
+166
| +23% | +$6.76K | ﹤0.01% | 942 |
|
|
2017
Q1 | $35K | Buy |
735
+328
| +81% | +$15.4K | ﹤0.01% | 925 |
|
|
2016
Q4 | $19K | Sell |
407
-27
| -6% | -$1.19K | ﹤0.01% | 2185 |
|
|
2016
Q3 | $17K | Sell |
434
-65
| -13% | -$2.73K | ﹤0.01% | 1709 |
|
|
2016
Q2 | $19K | Buy |
+499
| New | +$21.2K | ﹤0.01% | 2268 |
|
|
2016
Q1 | – | Sell |
-68
| Closed | -$3K | – | 4169 |
|
|
2015
Q4 | $3K | Buy |
68
+19
| +39% | +$941 | ﹤0.01% | 3400 |
|
|
2015
Q3 | $2K | Buy |
+49
| New | +$2.67K | ﹤0.01% | 3310 |
|
|
2014
Q4 | – | Sell |
-80
| Closed | -$6K | – | 4061 |
|
|
2014
Q3 | $6K | Buy |
80
+33
| +70% | +$2.63K | ﹤0.01% | 3147 |
|
|
2014
Q2 | $4K | Buy |
+47
| New | +$3.38K | ﹤0.01% | 2970 |
|
|
2014
Q1 | – | Sell |
-182
| Closed | -$9K | – | 4476 |
|
|
2013
Q4 | $9K | Buy |
182
+125
| +219% | +$5.87K | ﹤0.01% | 3076 |
|
|
2013
Q3 | $3K | Buy |
+57
| New | +$2.33K | ﹤0.01% | 3928 |
|
Other funds holding CCM
Tower Research Capital (TRC)'s CCM Position: Q1 2023 in Review
Tower Research Capital (TRC) sold out of Concord Medical Services (CCM) in Q1 2023, closing a stake of 10 shares.
Tower Research Capital (TRC) first reported a position in CCM in Q3 2013 and held it in 14 quarters. The position peaked at $35K in Q1 2017. 3 funds tracked by Wall St. Rank hold CCM as of Q1 2023.
- Tower Research Capital (TRC) reported no remaining Concord Medical Services position as of Q1 2023 after selling out during the quarter.
- Tower Research Capital (TRC) sold 10 Concord Medical Services shares in Q1 2023.
- Tower Research Capital (TRC) first reported a position in Concord Medical Services in Q3 2013 and held it in 14 quarters.
- Tower Research Capital (TRC)'s Concord Medical Services position peaked at $35K in Q1 2017.
- 3 funds tracked by Wall St. Rank held Concord Medical Services as of Q1 2023.
Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.